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Abstract 
Papillary cystadenoma lymphomatosum is a benign salivary gland tumor most frequently located in the parotid 
gland (Warthin’s tumor). Its presentation in other major, or in minor, salivary glands is rare. Clinically, it manifests 
as a slow growing tumor, fluctuant on palpation due to its cystic morphology. The treatment of choice is complete 
excision with wide tumor-free margins. We present a 73-year-old female patient with an asymptomatic tumor of 8 
years evolution in the right posterior area of the hard palate. We performed surgical excision and a biopsy, which 
was reported as papillary cystadenoma lymphomatosum. During the post-operative examination carried out after 
3 weeks, it was observed that the lesion had recurred. The lesion was re-operated, performing the excision with 
CO2 laser and including the periosteum to ensure complete resection of the tumor. At 10 months follow-up, there 
was no recurrence of the lesion. This article includes a review of this condition and discusses its most important 
clinical and pathologic features and therapeutic approaches.
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Introduction
Papillary cystadenoma lymphomatosum (PCL) was first 
described in 1929 by Warthin, receiving since then the 
name of Warthin’s tumor (WT) when present in the pa-
rotid gland. It is a benign salivary gland tumor most fre-
quently located in the parotid gland, its presentation in 
other major or minor salivary glands is extremely rare. It 
is a well defined entity, with a dual histological compo-
nent, oncocytic epithelium and a lymphoid stroma (1). 
It is believed that this lesion stems from ductal elements 
trapped and developing within the parotid lymph nodes, 
suggesting that the adenomatous cystic proliferation 
triggers a secondary lymphoid reactive response in the 
stroma (2-4). WT is the second most frequent benign tu-
mor of the salivary glands after pleomorphic adenoma, 
representing between 10% and 15% of the total (3,4). 
Over 80% of the cases are located in the superficial lobe 
of the parotid gland in close relation to the lymph nodes 
(2). Clinically, it manifests as a slow growing tumor, 
fluctuant on palpation due to its cystic structure, and 
about 10% of cases are bilateral. The treatment of choice 
for WT is surgical resection with tumor free margins, 
including an intraoperative histological study, always 
confirmed by posterior pathological analysis (1,3,5). 
Malignant cases of this neoplasm have been reported, origi-
nating from both the lymphoid and the epithelial compo-
nent, as well as the appearance of a leukemia or a metastatic 
melanoma in the lymphoid component of the tumor (6,7).
The purpose of this article is to present a case of pap-
illary cystadenoma lymphomatosum (Warthin-like) in 
a very unusual location and to analyze and discuss the 
main clinical and pathological features of this lesion.
Case Report
A 73-year-old, female, Caucasian patient, allergic to peni-
cillin and with a medical history of hypertension, depres-
sion and hypercholesterolemia for which she is treated 
pharmacologically with Simvastatin (Tarbis ®, Belmac, 
Zaragoza, Spain) 20 mg / 1 tablet a day, Lormetazepan 
(Noctamid ®, Shering, Lyz-Lez-Lannoy, France) 2 mg 
/ 1 tablet a day, Captopril (Cinfa ®, Cinfa, Pamplona, 
Spain) 25 mg / ½ tablet a day, Domperidona (Montilium 
®, Dr.Esteve, Barcelona, Spain) 10 mg / 1 tablet a day, 
sertraline hydrochloride (Besitran ®, Pfízer, Barcelona, 
Spain) 50 mg / 1 tablet a day and Omeprazole (Cuve ®, 
Cuvefarma, Cordoba, Spain ) 20 mg / 1 tablet a day. She 
has no related toxic habits and had been operated for a 
facial sebaceous cyst and two Caesarean sections.
She attended the Oral Surgery Service at the Dental 
Clinic of the University of Barcelona presenting a pain-
less tumor of 8 years evolution, on the right posterior 
part of the hard palate (Figure 1). The patient had been 
wearing upper and lower removable partial dentures for 
20 years. After referring irritation caused by trauma of 
the prosthesis on the lesion 3 months earlier the pros-
thesis had been adjusted, releasing the palate. The tumor 
persisted so the patient was referred to our department 
for diagnosis and treatment.
Examination revealed an erythematous tumor, 6 mm in 
diameter, multinodular on the surface, non-ulcerated and 
painless. A possible odontogenic origin was ruled out by 
a dental and intraoral radiographic examination. Com-
puted tomography showed no bone alterations in the 
area of the lesion.
All these data led to a presumptive diagnosis of benign 
salivary tumor (pleomorphic adenoma). An excisional 
biopsy of the lesion was performed under local anesthe-
sia with surgical scalpel (Figure 2), removing the entire 
Fig. 1. Initial palatal swelling, of erythematous, nodu-
lar appearance.
Fig. 2. Treatment of the lesion. Excisional biopsy exci-
sional with scalpel under local infiltrative anesthesia.
Fig. 3. Surgical reoperation. Excision of the lesion 
with CO2laser.
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tumor with tumor free margins but not including the pe-
riosteum. We placed an X suture which held a textured 
collagen dressing Lyostyp ® (Braun Aesculap AG, Tut-
tlingen, Germany) to promote hemostasis. The wound 
healed by secondary intention and there were no intra-
operative or postoperative complications.
The histopathological examination revealed a papillary 
cystadenoma lymphomatosum (Warthin-like) with cystic 
spaces lined by a papillary epithelial proliferation with a 
double layer of columnar eosinophilic cells. At the core 
of the papillary projections a variable amount of lym-
phoid tissue with mature lymphocytes was observed.
At the 3 weeks control it was found that the lesion had 
recurred, noticing again an asymptomatic erythematous 
tumor, 5 mm in diameter, and with clinical character-
istics identical to the original, so it was decided to re-
operate. On this occasion CO2 laser was used to resect 
the lesion including the periosteum to ensure a complete 
excision (Figure 3). The result of this second biopsy was 
again PCL. At one month follow-up it was noted that the 
surgical wound had healed without complications.
The monitoring protocol includes regular checks every 
6 months during the first year and every year thereafter. 
Currently, after 10 months of follow-up, there is no evi-
dence of recurrence of the lesion.
Discussion
PCL is a tumor almost exclusively of the parotid gland, 
its appearance in other salivary glands is very rare and 
controversial (3). Its possible origin is discussed by sev-
eral authors (2-4,8), including Thompson and Bryant 
(8), who see it as a true neoplastic proliferation of the 
channels of the salivary glands, while others (3) believe 
it has a reactive or metaplastic origin.
The first case of PCL located in minor salivary glands 
was described in 1954, with very few cases published in 
the literature since then (1,5,9). In the review published 
by Eveson and Cawson (3) in 1986 of 278 cases of WT, 
only 2 appeared in the submaxillary gland, and the most 
common location was the parotid gland with 99.2% of 
the cases. Toida et al. (10) in a clinicopathologic study of 
82 cases of tumors of the minor salivary glands found no 
case of PCL. Similarly, Jaber (11) in a series of 75 cases 
of tumors of the minor salivary glands found 26 located 
in the hard palate (34.6%) but no case corresponded to a 
PCL. Yih et al. (12) also published a retrospective study 
of 213 cases of minor salivary gland tumors, with 91 
cases (42.72%) located in the palate of which none was a 
PCL. In both studies (11,12) pleomorphic adenoma was 
the most frequent benign tumor, and mucoepidermoid 
carcinoma the most frequently diagnosed malignant tu-
mor.
WT appears in adults, presenting the highest incidence 
between the ages of 58 and 70 years (3,5). Regarding 
sex, for some authors the ratio between men and women 
is similar, 1.6:1 (3), although in this respect there is much 
controversy, as other authors (2,5) find a predominance 
of males versus females with a ratio of 5:1.
The most common location of PCL is the parotid gland, 
although some cases have been described in the buccal 
mucosa (1), submaxillary gland (3), lip and palate (1,5). 
In a large series (3), 99.2% of WT were located in the 
parotid gland and only 0.8% in the submaxillary gland.
The World Health Organization classifies WT within 
benign epithelial tumors. Macroscopically WT presents 
as a spherical or ovoid mass, with a dense fibrous cap-
sule and displaying multiple cystic compartments filled 
with a viscous yellow or dull brown material. However, 
Eveson and Cawson (5) found 77% of cases with an in-
complete capsule, a full capsule in 8% and 16% of tu-
mors in which there was no evidence of capsule.
Microscopically it is a well-circumscribed tumor, typi-
cally cystic and papillary, with an adenoid columnar 
eosinophilic oncocytic epithelial lining arranged in two 
layers resting on a background of lymphoid stroma. 
Electron microscopy confirms the massive accumulation 
of mitochondria in the cytoplasm of oxyphilic epithelial 
cells, as well as the presence of crystalloid structures 
within them. Immunohistochemistry has shown that 
most of these are B lymphocytes, 50% contain IgG, 33% 
IgA and the rest IgM, IgD and IgE (13). In regard to the 
relative amounts of lymphoid and epithelial components, 
several distinct subtypes of WT have been distinguished, 
pointing to an evolution in tumor progression based on 
the increase in the lymphoid component (2).
Some authors (2) consider WT to be an adenomatous 
epithelial proliferation that promotes a secondary lym-
phoid reaction mediated by intratumoral immunological 
phenomena.
Some malignant cases have been reported, in relation to 
both the epithelial and the lymphoid component, as well 
as the appearance of a leukemia or metastasis in the lat-
ter (6). Skalova et al. (7) presented a case of a squamous 
cell carcinoma derived from a PCL located in the parotid 
gland of an 80-year-old woman.
Clinically, the WT usually presents as a slow growing 
tumor, cases of to 20 years evolution having been pub-
lished (3). Our case with an 8-year evolution would be 
within these evolutionary parameters. Palpation of the 
tumor is often fluctuant given its cystic composition, and 
can vary in size from a few millimeters to centimeters. 
Accordingly, in the series of Eveson and Cawson (3), 56% 
of the tumors measured between 1 and 3 cm, 40% from 4 to 
6 cm and only one exceeded 10 cm in diameter.
The differential diagnosis of this malignancy should be 
performed preferably with pleomorphic adenoma and 
cystoadenoma (14). The anatomicopathological diagno-
sis is generally easy, but it also should be distinguished 
from canalicular adenoma, sialadenoma as well as from 
branchial cyst when involving the parotid gland.
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A scintigram with the radioisotope Technetium 99m 
pertechnetate is often helpful in the diagnosis of parotid 
tumors because the WT captures the isotope and behaves 
like a hot spot.
The treatment of choice for these tumors is local excision 
with a wide tumor free margin to prevent potential recur-
rence. It is important to bear in mind that when located 
in the parotid gland between 5 and 10% can be bilateral 
and 10 to 15% multicentric. In the series published by 
Eveson and Cawson (3), 30 were bilateral (5%), 3 cases 
(1%) recurred after one, 3 and 7 years, respectively.
We can conclude that PCL is a benign salivary gland tu-
mor; very rarely occurring in the minor salivary glands. 
The treatment of choice is surgical excision with tumor 
free margins to prevent recurrence and / or possible ma-
lignant transformation of this tumor. The possibility of 
recurrence in salivary tumors requires scheduling regu-
lar checks every 6 months for at least 10 years. 
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